Thomas J. Lynch Jr. - Jun 17, 2025 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Thomas J. Lynch Jr.
Stock symbol
FHTX
Transactions as of
Jun 17, 2025
Transactions value $
$119,750
Form type
4
Date filed
6/17/2025, 04:28 PM
Previous filing
Jun 28, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lynch Thomas J. Jr. Director 500 TECHNOLOGY SQUARE, STE #700, CAMBRIDGE /s/ Michael LaCascia, Attorney-in-Fact for Thomas J. Lynch Jr. 2025-06-17 0001474056

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $120K +25K $4.79 25K Jun 17, 2025 Common Stock 25K $4.79 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.